Gene Regulation Map Reveals Treatment Targets for Heart Failure

Researchers at UC San Diego have mapped the gene regulation networks that drive heart failure. This study provides a detailed view of how genes are controlled within specific cell types during the progression of the disease. Published in the journal Science, the findings help resolve why heart failure remains difficult to treat. Most genetic risk for heart disease resides in noncoding DNA regions rather than the genes themselves. These regions act as control switches. Because current treatments often lack clear biological targets, identifying these switches offers a path toward new precision medicine therapies.

The research team analyzed heart tissue from 36 individuals, examining more than 750,000 individual heart cells. By integrating multiple layers of genomic data, they identified 12 major cardiac cell types and numerous subpopulations. They observed significant shifts in cell composition, including an increase in fibroblasts that produce scar tissue and a reduction in cardiomyocytes that handle contraction. The study tracked how these cells move through intermediate states, providing researchers with specific points of intervention.

This atlas connects genetic risk to specific biological mechanisms. By pinpointing how disease-associated DNA changes influence gene expression in cardiomyocytes, the team has created a framework for future drug development. The researchers are now developing pipelines to test candidate targets identified through this data. This work moves the field beyond general observations toward identifying the precise mechanisms that trigger the transition from a healthy to a failing heart. It establishes a resource for the scientific community to develop therapies that act on the right cells at the right time.